X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/09/2860339/0/en/Corvus-Pharmaceuticals-Announces-Initiation-of-Placebo-Controlled-Phase-1-Clinical-Trial-of-Soquelitinib-for-Atopic-Dermatitis.html
https://www.globenewswire.com/news-release/2024/03/19/2848959/0/en/Corvus-Pharmaceuticals-Provides-Business-Update-and-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results.html
https://www.globenewswire.com//news-release/2024/03/13/2845827/0/en/Corvus-Pharmaceuticals-to-Provide-Business-Update-and-Fourth-Quarter-and-Full-Year-2023-Financial-Results-on-March-19-2024.html
https://www.globenewswire.com//news-release/2024/02/12/2827524/0/en/Corvus-Pharmaceuticals-Presents-Soquelitinib-Preclinical-Data-at-the-Keystone-Symposia-on-Systemic-Autoimmune-and-Autoinflammatory-Diseases.html
https://www.globenewswire.com//news-release/2024/02/08/2826449/0/en/Corvus-Pharmaceuticals-Announces-Orphan-Drug-Designation-Granted-to-Soquelitinib-for-the-Treatment-of-T-Cell-Lymphoma.html
https://www.globenewswire.com//news-release/2024/02/06/2824733/0/en/Corvus-Pharmaceuticals-Appoints-Jeffrey-Arcara-as-Chief-Business-Officer.html
https://www.globenewswire.com//news-release/2024/01/23/2814564/0/en/Corvus-Pharmaceuticals-Announces-the-Passing-of-Board-Member-Edith-P-Mitchell.html
https://www.globenewswire.com//news-release/2023/12/09/2793436/0/en/Corvus-Pharmaceuticals-Presents-New-Interim-Soquelitinib-Data-from-its-Phase-1-1b-T-Cell-Lymphoma-Trial.html
https://www.globenewswire.com//news-release/2023/11/07/2775563/0/en/Corvus-Pharmaceuticals-Provides-Business-Update-and-Reports-Third-Quarter-2023-Financial-Results.html
https://www.globenewswire.com//news-release/2023/11/02/2772456/0/en/Corvus-Pharmaceuticals-to-Present-New-Interim-Soquelitinib-Data-from-its-Phase-1-1b-T-Cell-Lymphoma-Trial-at-the-65th-American-Society-of-Hematology-ASH-Annual-Meeting-Exposition.html
Market Place
Share 
